Cardiff Oncology

$11.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.46 (-3.97%) Today
+$0.66 (+5.92%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CRDF and other stocks, options, and ETFs commission-free!

About CRDF

Cardiff Oncology, Inc. Common Stock, also called Cardiff Oncology, is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA. The listed name for CRDF is Cardiff Oncology, Inc. Common Stock.

CEO
Mark Erlander
Employees
14
Headquarters
San Diego, California
Founded
1999
Market Cap
393.52M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.43M
High Today
$11.92
Low Today
$10.21
Open Price
$11.77
Volume
7.09M
52 Week High
$25.50
52 Week Low
$0.701

Collections

CRDF Earnings

-$0.79
-$0.53
-$0.26
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, After Hours

You May Also Like

WTRU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure